# A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute Gastroenteritis

> **NCT02699385** · PHASE3 · TERMINATED · sponsor: **Janssen-Cilag International NV** · enrollment: 10 (actual)

## Conditions studied

- Gastroenteritis

## Interventions

- **OTHER:** Oral Rehydration Therapy
- **DRUG:** Domperidone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02699385
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12-07
- **Primary completion:** 2017-08-03
- **Final completion:** 2017-08-03
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Study prematurely terminated upon recommendation of IDMC due to lack of efficacy.
- **Last updated:** 2019-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02699385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02699385, "A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute Gastroenteritis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02699385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*